Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. - Test2 - elhamkhani - TriplyDB

Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

http://www.wikidata.org/entity/Q34318250

about

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy Recent advances in the understanding and management of IgA nephropathy New developments in the genetics, pathogenesis, and therapy of IgA nephropathy Genetic studies of IgA nephropathy: what have we learned from genome-wide association studies Current Understanding of the Role of Complement in IgA Nephropathy Genetic and epigenetic factors influencing chronic kidney disease The Genetics of IgA Nephropathy: An Overview from Western Countries Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures Insights into kidney diseases from genome-wide association studies.Genome-wide association studies in pediatric chronic kidney disease.Complement factor H gene associations with end-stage kidney disease in African Americans.Cumulative effects of variants identified by genome-wide association studies in IgA nephropathy.Long-term prognosis of clinically early IgA nephropathy is not always favorable.The genetics and immunobiology of IgA nephropathy.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.The coincidence of IgA nephropathy and Fabry disease Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study.Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy Identification of new susceptibility loci for IgA nephropathy in Han Chinese.Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway Changes in the clinical presentation of immunoglobulin A nephropathy: data from the Spanish Registry of Glomerulonephritis.Primary glomerulonephritis: A review of important recent discoveries.CKD Prevalence Varies across the European General Population Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy.Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment.Perceptions regarding genetic testing in populations at risk for nephropathy.Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.Glomerular diseases: emerging tests and therapies for IgA nephropathy Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.Novel biomarkers in glomerular disease.Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model Aging promotes progression of IgA nephropathy: a systematic review and meta-analysis.Biomarkers in IgA nephropathy: relationship to pathogenetic hits.Association of megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy.

P2860

Q26752555-CA9E6401-5DB4-4115-9840-3A5BD8837AD9 Q26766126-ADDB7BF7-1491-42BA-81A6-1839448CABD1 Q26786248-93AB5A46-F180-4CEB-8DBD-915DD3F0964F Q26829467-D2540520-1F59-46C4-83E1-92F0C14859EF Q26852163-642E1F12-5FB2-435B-88F3-D3CF181F30CF Q27024548-07FDF634-1A32-4EB1-9B3A-5ACDC998B1CA Q28085181-32C68A41-8258-455E-A425-FBC668A208EF Q28391758-56AE039F-52AB-4038-B219-79091133355B Q30248678-FD22A7ED-5A37-44AD-B8A0-BB311B4596FA Q30252068-E0DA6AC0-A771-4358-942C-F6E53220EE11 Q30384517-F480A025-ADD3-4FBC-946C-CBB1940D5119 Q33585514-D1F250BD-E188-42A0-A4C7-7568971C08B5 Q33804280-E03E97AD-D8C5-4F6E-AB51-F57639C359F6 Q33872517-1E576209-F2BE-41F9-A69D-D4BBA9A4BD36 Q33932951-31704AE6-D6C8-4FD2-8417-E7D33A6A6AF8 Q34422205-1679C39D-E0EE-4F87-BE66-81E06A28E8C1 Q34543669-B9A81C24-F9B7-4FF3-AFB2-B2031BF6FAFE Q34683659-C47EFD37-54FC-4B43-A4BF-53E284FB5D84 Q34998144-2CA84068-F610-4E4B-88BE-A66788720839 Q35550560-885AFD1E-0FFB-4C45-B7DD-7F1BF3BE8292 Q35692714-E2EB90D9-7318-4F19-BE3F-47C080BDAACB Q36113184-2614C06D-26AB-46DF-8D7F-4469D5797B49 Q36119937-8AA971DD-7271-4CA9-B754-5C2C0FC21DF6 Q36122055-FAC5C2C6-F3CC-414D-9AF6-2D477D650643 Q36276884-A7CD97E6-4E92-4603-AF0E-807DDE26EC91 Q36359848-9D641252-37EF-4644-8D49-FEDD31F54A21 Q36465902-4AEB9205-6870-4FBF-BE7E-E27920CCB37C Q37052038-2469883B-FC4C-4FE1-98A7-67873B6476BD Q37205233-5B19FC0B-93FB-464C-BF56-D24312788E30 Q37524989-413DC55E-2382-414F-9491-F9AD5DB24EBD Q37555991-5D89D509-7CB7-41ED-9D13-873621A9287E Q37578868-56A0EB8D-487F-4C8D-AB23-AF24D2CD7D48 Q37596411-AFBEEA17-258B-45CD-BB24-F026B79AAD2E Q37621563-B3D9E12B-94AC-455C-9A1E-EFA11C04770F Q37631861-664150EE-595D-4B30-9118-F9C38FF82D2C Q37658483-7032DCEB-9F49-4D19-B625-D066EA8E7C00 Q37742691-98A46C33-6391-4049-8BD8-E52A87776AA3 Q38136018-7B1E8B7A-9310-4782-AE1A-39E21560EA5A Q38157013-8494B969-622B-4DEB-8CB3-5CC18A9DD6C0 Q38191664-5CED89F5-2553-4053-9EA9-4A2FBACAAF70

P2860

Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

http://www.wikidata.org/entity/Q34318250

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Geographic differences in gene ...... and geospatial risk analysis.

@ast

Geographic differences in gene ...... and geospatial risk analysis.

@en

Geographic differences in gene ...... and geospatial risk analysis.

@nl

type

label

Geographic differences in gene ...... and geospatial risk analysis.

@ast

Geographic differences in gene ...... and geospatial risk analysis.

@en

Geographic differences in gene ...... and geospatial risk analysis.

@nl

prefLabel

Geographic differences in gene ...... and geospatial risk analysis.

@ast

Geographic differences in gene ...... and geospatial risk analysis.

@en

Geographic differences in gene ...... and geospatial risk analysis.

@nl

P1433

Q34318250-D230ED2F-24EA-4A47-B1BF-169A7A737484

P1476

Q34318250-85996A0F-ED7E-4B32-8D21-C0C3A7171662

P2093

Q34318250-08B1BA1A-0113-49D6-B18D-3A29D03C763B

Q34318250-13C8AAD7-3577-4B24-80D0-08FBB53BDBB5

Q34318250-20B990B6-23E0-43A0-8F0A-D689CF8DBBAA

Q34318250-2287EEF2-FBF1-4D44-8128-D750E115E263

Q34318250-26720102-8B67-4D48-B9AE-65BF2FD2F6D5

Q34318250-28B8ACD5-B922-44F8-A68D-222AFC6D3F79

Q34318250-2D3ACF8A-7A4E-4975-826A-9ED76C2BE644

Q34318250-456C696A-D60C-4F9A-85D3-48B5C9684583

Q34318250-4C5FFEA6-2734-47FE-A7F7-67A0C8042379

Q34318250-4F16F03E-48F9-4ED5-9F38-EA0F7B1A4254

P2860

Q34318250-04121DA5-4F35-4E01-95A3-CB2767138A3E

Q34318250-065F4DAB-8109-4E72-8D0C-E5B0AC7D434A

Q34318250-1E04021C-1432-4ABD-A83C-B9B10BD5D1F3

Q34318250-23279C4F-193D-40D8-BB90-2A167A131796

Q34318250-2E99D289-F0D4-485C-8293-85CD935FDD9F

Q34318250-347DC40A-05A6-47FE-B8BF-79A0DBBE09F4

Q34318250-39D1536D-B6C4-429D-BFA0-614695383794

Q34318250-3FE2EA9E-140A-4F40-94B6-0C9E021A02AA

Q34318250-43BFC4FE-9911-475E-8DAE-7278A2A86FC5

Q34318250-454491C6-3823-470E-A457-B428AB8477A9

P304

Q34318250-369F7D04-EDF2-48D7-A143-988FDDEE107A

P31

Q34318250-636EDBB1-8BD5-490C-8F66-42B7F7E01A28

Q34318250-787e09e3-d500-4c34-9004-c1a5a5ce927b

P356

Q34318250-E839F1E9-4D8F-4215-9A93-DE17DBD5146F

P433

Q34318250-FA784287-3F14-41C0-9C1C-BF2B1F45E657

P478

Q34318250-2949D6A0-6784-4F36-A395-3426159493A2

P50

Q34318250-23553C87-4DD1-4E72-A0DF-05D324200F08

Q34318250-2D76B7C5-CF85-4679-A2E0-43975973DC87

Q34318250-4F4F2732-9842-415C-B284-115D2D3DFECE

Q34318250-50E548D0-5FEF-41C6-B43A-0629A07181E1

Q34318250-536215E9-9874-492C-9F44-0CC7AB9FAD69

Q34318250-63AF7573-2CD7-4FFE-AAAF-E1F2E7F9CDC6

Q34318250-6D267DF8-0A2A-421C-9DC6-C71FE3921E3A

Q34318250-93567EE4-7417-420F-9C4E-A139503AC93D

Q34318250-9BB1DD3F-EE65-4761-A5D1-05A677ED5A4D

Q34318250-AB2EF091-99EB-4EE8-9ACB-689D68F4844B

P577

Q34318250-803A864E-C238-427E-965C-6F070C6CC92D

P5875

Q34318250-678E7232-4900-44DE-9870-306F0C638AE5

P698

Q34318250-3225C4C7-1F66-4666-A74A-6788125C6F30

P921

Q34318250-5D8AB988-AF1B-43B0-ABDC-488D31991251

P932

Q34318250-C9FC6BE8-2883-4BB8-8440-B3FE90E18FA6

P356

JOURNAL.PGEN.1002765

P1433

P1476

Geographic differences in gene ...... and geospatial risk analysis.

@en

P2093

Ali G Gharavi

http://www.w3.org/2001/XMLSchema#string

Anne Boland

http://www.w3.org/2001/XMLSchema#string

Bruce A Julian

http://www.w3.org/2001/XMLSchema#string

Christoph Wanner

http://www.w3.org/2001/XMLSchema#string

Claudia Izzi

http://www.w3.org/2001/XMLSchema#string

Daniele Cusi

http://www.w3.org/2001/XMLSchema#string

Dita Maixnerova

http://www.w3.org/2001/XMLSchema#string

Francesco Scolari

http://www.w3.org/2001/XMLSchema#string

Francois Berthoux

http://www.w3.org/2001/XMLSchema#string

Frank Eitner

http://www.w3.org/2001/XMLSchema#string

P2860

High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions

Multiple sclerosis: Geoepidemiology, genetics and the environment

New loci associated with kidney function and chronic kidney disease

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

PLINK: a tool set for whole-genome association and population-based linkage analyses

The pathophysiology of IgA nephropathy

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes

P304

e1002765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PGEN.1002765

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gudmar Thorleifsson

Unnur Þorsteinsdóttir

Kati Kristiansson

Krzysztof Mucha

Patrik K E Magnusson

Maddalena Gigante

Alexander Viktorin

Benedicte Stengel

P577

2012-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228071889

http://www.w3.org/2001/XMLSchema#string

P698

22737082

http://www.w3.org/2001/XMLSchema#string

P921

genome-wide association study

P932

3380840

http://www.w3.org/2001/XMLSchema#string